IGF1R and Alzheimer disease: However, this model is not generally applicable, because no sexual dimorphism was reported upon Igf-1r+/− mice 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment [40] or when crossed to AD mouse models [27].